Orca Bio, Inc.

Orca Bio is a late-stage biotechnology company developing high-precision allogeneic T-cell immunotherapies for cancer and autoimmune diseases. Their mission is to deliver effective cell therapies to patients without compromise, focusing on better outcomes with fewer risks.